SCHEMBL22640191

SCHEMBL22640191

CC(F)C(=O)NCCCC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](CCc1ccc2ccccc2c1)NC(=O)[C@@H](Cc1ccc2ccccc2c1)NC(=O)C1CCNCC1)C(N)=O

nearest known ligand 0.46

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ KISS1R Q969F8 3/20 0.46
▸ PLG P00747 3/20 0.46
▸ PRSS1 P07477 3/20 0.46
▸ PRSS2 P07478 3/20 0.46
▸ PRSS3 P35030 3/20 0.46
▸ FOLH1 Q04609 3/20 0.45
▸ QRFPR Q96P65 2/20 0.44
▸ MC4R P32245 2/20 0.43
▸ MC3R P41968 1/20 0.43
▸ MC1R Q01726 1/20 0.43
▸ NMUR2 Q9GZQ4 2/20 0.43
▸ NMUR1 Q9HB89 2/20 0.43
▸ CDYL2 Q8N8U2 1/20 0.42
▸ CDYL Q9Y232 1/20 0.42
▸ CAPN1 P07384 1/20 0.42
▸ CTSL P07711 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22640195 0.97 PLG (0.49) KISS1RPLGPRSS1PRSS2PRSS3
SCHEMBL20228992 0.94 PLG (0.51) KISS1RPLGPRSS1PRSS2PRSS3
SCHEMBL22640189 0.93 PLG (0.49) KISS1RPLGPRSS1PRSS2PRSS3
SCHEMBL20228973 0.90 KISS1R (0.41) KISS1RPLGPRSS1PRSS2PRSS3
SCHEMBL22640190 0.90 PLG (0.52) KISS1RPLGPRSS1PRSS2PRSS3
SCHEMBL20228991 0.88 PLG (0.42) KISS1RPLGPRSS1PRSS2PRSS3
SCHEMBL20228972 0.83 PLG (0.45) KISS1RPLGPRSS1PRSS2PRSS3
SCHEMBL14527564 0.82 CAPN1 (0.51) PLGPRSS1PRSS2PRSS3MC4R
SCHEMBL20228974 0.82 PLG (0.45) KISS1RPLGPRSS1PRSS2PRSS3
SCHEMBL14527547 0.80 CAPN1 (0.58) MC4RMC3RMC1RCAPN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10829516-B2 Peptidomimetics for imaging the ghrelin receptor LONDON HEALTH SCIENCES CENTRE RESEARCH INC. (CA) 2020-11-10 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10829516-B2 Peptidomimetics for imaging the ghrelin receptor GHSR, GRPR, GHRHR KISS1R 79/4885PLG 1365/4885PRSS1 1778/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback